The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Novartis AG

NYSE: NVS
Last

(U.S.) $103.83

Today's change+0.64 +0.63%
Updated July 31 3:00 PM EDT. Delayed by at least 15 minutes.
 

Novartis AG

NYSE: NVS
Last

(U.S.) $103.83

Today's change+0.64 +0.63%
Updated July 31 3:00 PM EDT. Delayed by at least 15 minutes.

Novartis AG up (U.S.)$0.64

Novartis AG is up today by (U.S.)$0.64 or 0.63% to (U.S.)$103.83. Over the last five days, shares have gained 1.99% and are currently 2.82% off of the 52-week high. Shares have outperformed the S&P 500 by 10.36% during the last year.

Key company metrics

  • Open(U.S.) $104.50
  • Previous close(U.S.) $103.18
  • High(U.S.) $104.75
  • Low(U.S.) $103.75
  • Bid / Ask(U.S.) $103.81 / (U.S.) $103.84
  • YTD % change+12.05%
  • Volume1,089,996
  • Average volume (10-day)1,985,253
  • Average volume (1-month)2,268,826
  • Average volume (3-month)1,590,524
  • 52-week range(U.S.) $84.17 to (U.S.) $106.84
  • Beta0.56
  • Trailing P/E26.25×
  • P/E 1 year forward20.05×
  • Forward PEG3.18×
  • Indicated annual dividend(U.S.) $2.67
  • Dividend yield2.57%
  • Trailing EPS(U.S.) $3.95
Updated July 31 3:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+18.77%

Based on its net profit margin of 18.77%, Novartis AG is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.56%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue12,89612,20213,35413,300
Total other revenue--------
Total revenue12,89612,20213,35413,300
Gross profit8,4098,2228,9388,879
Total cost of revenue4,4873,9804,4164,421
Total operating expense10,6159,41711,00310,561
Selling / general / administrative3,6173,2823,9653,565
Research & development2,2062,0672,5372,161
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total3058885414
Operating income2,2812,7852,3512,739
Interest income (expense), net non-operating-164-179-188-182
Gain (loss) on sale of assets--------
Other--------
Income before tax2,1562,6782,7563,532
Income after tax1,8562,3062,4483,102
Income tax, total300372308430
Net income1,83613,0051,4913,223
Total adjustments to net income--------
Net income before extra. items1,8542,3062,4523,085
Minority interest-204-17
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,8542,3062,4523,085
Inc. avail. to common incl. extra. items1,83613,0051,4913,223
Diluted net income1,83613,0131,4913,223
Dilution adjustment--800
Diluted weighted average shares2,4482,4462,4582,460
Diluted EPS excluding extraordinary itemsvalue per share0.760.951.001.25
Dividends per sharevalue per share0.000.002.760.00
Diluted normalized EPSvalue per share0.870.981.061.36